Latest Update: Impact of current COVID-19 situation has been considered in this report while making the analysis.
Global Atrial Fibrillation Devices Market by Type (Catheter Ablation, Maze Surgery), By Application (Hospitals, Clinics, Ambulatory Surgical Centers, Others) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030-report

Global Atrial Fibrillation Devices Market by Type (Catheter Ablation, Maze Surgery), By Application (Hospitals, Clinics, Ambulatory Surgical Centers, Others) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030

Report ID: 169629 3300 Medical Devices & Consumables 377 241 Pages 4.8 (50)
                                          

Market Overview:


The global atrial fibrillation devices market is expected to grow from USD 2.5 billion in 2018 to USD 4.1 billion by 2030, at a CAGR of 6.4% during the forecast period. The growth of this market can be attributed to the increasing prevalence of atrial fibrillation, technological advancements in atrial fibrillation devices, and rising geriatric population. However, the high cost of treatment and lack of reimbursement are restraining the growth of this market. Based on type, the global atrial fibrillation devices market is segmented into catheter ablation and maze surgery.


Global Atrial Fibrillation Devices Industry Outlook


Product Definition:


Atrial fibrillation (AF) is a heart rhythm disorder that can cause blood clots, stroke, and heart failure. AF occurs when the electrical signals in the atria (upper chambers of the heart) become disorganized and start to fire erratically. This causes the atria to quiver instead of contracting normally, which interferes with blood flow from the atria to the ventricles (lower chambers of the heart). Devices used for treating Atrial Fibrillation are called "atrial fibrillation devices.


Catheter Ablation:


Atrial fibrillation is a type of cardiac arrhythmia, which is caused by irregular electrical activities in the atria. The rate of these irregular heartbeats can range from 40 to 100 times per minute. This condition may lead to blood clots forming in the heart and causing a stroke or heart attack.


Maze Surgery:


Maze surgery is a minimally invasive surgical procedure used to treat irregular heartbeats or arrhythmias. It involves mapping out the electrical pathways in the heart using special instruments and then cutting those pathways to cure the problem. The pathway that is cut forms a loop, which causes less strain on the heart and helps it function normally.


Application Insights:


Based on application, the global atrial fibrillation devices market is segmented into hospitals, clinics and ambulatory surgical centers, and others. Hospitals held the largest share in 2017 owing to availability of advanced healthcare facilities along with highly skilled medical staff. In addition, hospitals are considered to be one of the best places for interventional procedures due to availability of highly skilled surgeons as well as equipment required for such procedures.


Hence, atrial fibrillation patients who require surgery are referred by their cardiologists to a hospital where they can get it done without any complications or additional costs. However, majority of these surgeries are conducted in specialized cardiac surgery units within hospitals which limits its use outside these settings thus accounting for a smaller share in comparison with other segments during recent years.


Regional Analysis:


North America dominated the global market in 2017 owing to the increasing prevalence of AF and its treatment. The U.S., which is a developed economy, accounted for a major share in North America due to technological advancements coupled with high healthcare expenditure levels.


Asia Pacific is expected to grow at an exponential rate over the forecast period owing to increasing awareness about AF and its associated risks, growing population base, rising disposable income levels, and availability of effective treatment methods in this region. Japan accounts for a significant share as Maze procedure was introduced there first than anywhere else in the world thus making it one of the largest markets worldwide.


Growth Factors:


  • Increasing prevalence of atrial fibrillation (AF) is expected to drive the demand for atrial fibrillation devices over the forecast period. According to American Heart Association, around 5 million people in the U.S. are affected by AF and this number is expected to grow due to increasing aging population.
  • Rising geriatric population is also a major factor that will contribute towards growth of atrial fibrillation devices market as incidence of AF increases with age. According to World Health Organization, global geriatric population was estimated 7% in 2000 and is projected to reach 21% by 2050.

Scope Of The Report

Report Attributes

Report Details

Report Title

Atrial Fibrillation Devices Market Research Report

By Type

Catheter Ablation, Maze Surgery

By Application

Hospitals, Clinics, Ambulatory Surgical Centers, Others

By Companies

Abbott, Boston Scientific, Biosense Webster, Medtronic, Japan Lifeline, AtriCure, Biotronik, Philips, Synaptic Medical, Osypka AG, MicroPort Scientific, CardioFocus, Lepu Medical, APT Med, TZ Medical

Regions Covered

North America, Europe, APAC, Latin America, MEA

Base Year

2021

Historical Year

2019 to 2020 (Data from 2010 can be provided as per availability)

Forecast Year

2030

Number of Pages

241

Number of Tables & Figures

169

Customization Available

Yes, the report can be customized as per your need.


Global Atrial Fibrillation Devices Market Report Segments:

The global Atrial Fibrillation Devices market is segmented on the basis of:

Types

Catheter Ablation, Maze Surgery

The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.

Applications

Hospitals, Clinics, Ambulatory Surgical Centers, Others

The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.

Some of the companies that are profiled in this report are:

  1. Abbott
  2. Boston Scientific
  3. Biosense Webster
  4. Medtronic
  5. Japan Lifeline
  6. AtriCure
  7. Biotronik
  8. Philips
  9. Synaptic Medical
  10. Osypka AG
  11. MicroPort Scientific
  12. CardioFocus
  13. Lepu Medical
  14. APT Med
  15. TZ Medical

Global Atrial Fibrillation Devices Market Overview


Highlights of The Atrial Fibrillation Devices Market Report:

  1. The market structure and projections for the coming years.
  2. Drivers, restraints, opportunities, and current trends of market.
  3. Historical data and forecast.
  4. Estimations for the forecast period 2030.
  5. Developments and trends in the market.
  6. By Type:

    1. Catheter Ablation
    2. Maze Surgery
  1. By Application:

    1. Hospitals
    2. Clinics
    3. Ambulatory Surgical Centers
    4. Others
  1. Market scenario by region, sub-region, and country.
  2. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
  3. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
  4. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Atrial Fibrillation Devices Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.

Regional Analysis

  • North America
  • Europe
  • Asia Pacific
  • Middle East & Africa
  • Latin America

Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.

The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.

How you may use our products:

  • Correctly Positioning New Products
  • Market Entry Strategies
  • Business Expansion Strategies
  • Consumer Insights
  • Understanding Competition Scenario
  • Product & Brand Management
  • Channel & Customer Management
  • Identifying Appropriate Advertising Appeals

Global Atrial Fibrillation Devices Market Statistics

8 Reasons to Buy This Report

  1. Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
  2. Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
  3. Implemented Robust Methodology to Prepare the Report
  4. Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
  5. Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
  6. Provides Information About the Top-winning Strategies Implemented by Industry Players.
  7. In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
  8. Customization of the Report Available

Frequently Asked Questions?


Atrial Fibrillation Devices are medical devices that help to reduce the risk of stroke in people with atrial fibrillation. These devices can include an implantable cardioverter-defibrillator (ICD) or a pacemaker.

Some of the major players in the atrial fibrillation devices market are Abbott, Boston Scientific, Biosense Webster, Medtronic, Japan Lifeline, AtriCure, Biotronik, Philips, Synaptic Medical, Osypka AG, MicroPort Scientific, CardioFocus, Lepu Medical, APT Med, TZ Medical.

The atrial fibrillation devices market is expected to register a CAGR of 6.4%.

                                            
1. Executive Summary

2. Assumptions and Acronyms Used

3. Research Methodology

4. Atrial Fibrillation Devices Market Overview
   4.1. Introduction
      4.1.1. Market Taxonomy
      4.1.2. Market Definition
   4.2. Macro-Economic Factors
      4.2.1. Industry Outlook
   4.3. Atrial Fibrillation Devices Market Dynamics
      4.3.1. Market Drivers
      4.3.2. Market Restraints
      4.3.3. Opportunity
      4.3.4. Market Trends
   4.4. Atrial Fibrillation Devices Market - Supply Chain
   4.5. Global Atrial Fibrillation Devices Market Forecast
      4.5.1. Atrial Fibrillation Devices Market Size (US$ Mn) and Y-o-Y Growth
      4.5.2. Atrial Fibrillation Devices Market Size (000’ Units) and Y-o-Y Growth
      4.5.3. Atrial Fibrillation Devices Market Absolute $ Opportunity

5. Global Atrial Fibrillation Devices Market Analysis and Forecast by Type
   5.1. Market Trends
   5.2. Introduction
      5.2.1. Basis Point Share (BPS) Analysis by Type
      5.2.2. Y-o-Y Growth Projections by Type
   5.3. Atrial Fibrillation Devices Market Size and Volume Forecast by Type
      5.3.1. Catheter Ablation
      5.3.2. Maze Surgery
   5.4. Absolute $ Opportunity Assessment by Type
   5.5. Market Attractiveness/Growth Potential Analysis by Type

6. Global Atrial Fibrillation Devices Market Analysis and Forecast by Application
   6.1. Market Trends
   6.2. Introduction
      6.2.1. Basis Point Share (BPS) Analysis by Application
      6.2.2. Y-o-Y Growth Projections by Application
   6.3. Atrial Fibrillation Devices Market Size and Volume Forecast by Application
      6.3.1. Hospitals
      6.3.2. Clinics
      6.3.3. Ambulatory Surgical Centers
      6.3.4. Others
   6.4. Absolute $ Opportunity Assessment by Application
   6.5. Market Attractiveness/Growth Potential Analysis by Application

7. Global Atrial Fibrillation Devices Market Analysis and Forecast by Sales Channel
   7.1. Market Trends
   7.2. Introduction
      7.2.1. Basis Point Share (BPS) Analysis by Sales Channel 
      7.2.2. Y-o-Y Growth Projections by Sales Channel
   7.3. Atrial Fibrillation Devices Market Size and Volume Forecast by Sales Channel 
      7.3.1. Manufacturer/Distributor/Service Provider
      7.3.2. Aftermarket
   7.4. Absolute $ Opportunity Assessment by Sales Channel
   7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel

8. Global Atrial Fibrillation Devices Market Analysis and Forecast by Region
   8.1. Market Trends
   8.2. Introduction
      8.2.1. Basis Point Share (BPS) Analysis by Region
      8.2.2. Y-o-Y Growth Projections by Region
   8.3. Atrial Fibrillation Devices Market Size and Volume Forecast by Region
      8.3.1. North America
      8.3.2. Latin America
      8.3.3. Europe
      8.3.4. Asia Pacific
      8.3.5. Middle East and Africa (MEA)
   8.4. Absolute $ Opportunity Assessment by Region
   8.5. Market Attractiveness/Growth Potential Analysis by Region
   8.6. Global Atrial Fibrillation Devices Demand Share Forecast, 2019-2026

9. North America Atrial Fibrillation Devices Market Analysis and Forecast
   9.1. Introduction
      9.1.1. Basis Point Share (BPS) Analysis by Country
      9.1.2. Y-o-Y Growth Projections by Country
   9.2. North America Atrial Fibrillation Devices Market Size and Volume Forecast by Country
      9.2.1. U.S.
      9.2.2. Canada
   9.3. Absolute $ Opportunity Assessment by Country
   9.4. North America Atrial Fibrillation Devices Market Size and Volume Forecast by Application
      9.4.1. Hospitals
      9.4.2. Clinics
      9.4.3. Ambulatory Surgical Centers
      9.4.4. Others
   9.5. Basis Point Share (BPS) Analysis by Application
   9.6. Y-o-Y Growth Projections by Application
   9.7. North America Atrial Fibrillation Devices Market Size and Volume Forecast by Type
      9.7.1. Catheter Ablation
      9.7.2. Maze Surgery
   9.8. Basis Point Share (BPS) Analysis by Type
   9.9. Y-o-Y Growth Projections by Type
   9.10. Market Attractiveness/Growth Potential Analysis
      9.10.1. By Country
      9.10.2. By Product Type
      9.10.3. By Application
      9.10.4. By Sales Channel
   9.11. North America Atrial Fibrillation Devices Demand Share Forecast, 2019-2026

10. Latin America Atrial Fibrillation Devices Market Analysis and Forecast
   10.1. Introduction
      10.1.1. Basis Point Share (BPS) Analysis by Country
      10.1.2. Y-o-Y Growth Projections by Country
      10.1.3. Latin America Average Pricing Analysis
   10.2. Latin America Atrial Fibrillation Devices Market Size and Volume Forecast by Country
      10.2.1. Brazil
      10.2.2. Mexico
      10.2.3. Rest of Latin America
   10.3. Absolute $ Opportunity Assessment by Country
   10.4. Latin America Atrial Fibrillation Devices Market Size and Volume Forecast by Application
      10.4.1. Hospitals
      10.4.2. Clinics
      10.4.3. Ambulatory Surgical Centers
      10.4.4. Others
   10.5. Basis Point Share (BPS) Analysis by Application
   10.6. Y-o-Y Growth Projections by Application
   10.7. Latin America Atrial Fibrillation Devices Market Size and Volume Forecast by Type
      10.7.1. Catheter Ablation
      10.7.2. Maze Surgery
   10.8. Basis Point Share (BPS) Analysis by Type
   10.9. Y-o-Y Growth Projections by Type
   10.10. Market Attractiveness/Growth Potential Analysis
      10.10.1. By Country
      10.10.2. By Product Type
      10.10.3. By Application
      10.10.4. By Sales Channel
   10.11. Latin America Atrial Fibrillation Devices Demand Share Forecast, 2019-2026

11. Europe Atrial Fibrillation Devices Market Analysis and Forecast
   11.1. Introduction
      11.1.1. Basis Point Share (BPS) Analysis by Country
      11.1.2. Y-o-Y Growth Projections by Country
      11.1.3. Europe Average Pricing Analysis
   11.2. Europe Atrial Fibrillation Devices Market Size and Volume Forecast by Country
      11.2.1. Germany
      11.2.2. France
      11.2.3. Italy
      11.2.4. U.K.
      11.2.5. Spain
      11.2.6. Russia
      11.2.7. Rest of Europe
   11.3. Absolute $ Opportunity Assessment by Country
   11.4. Europe Atrial Fibrillation Devices Market Size and Volume Forecast by Application
      11.4.1. Hospitals
      11.4.2. Clinics
      11.4.3. Ambulatory Surgical Centers
      11.4.4. Others
   11.5. Basis Point Share (BPS) Analysis by Application
   11.6. Y-o-Y Growth Projections by Application
   11.7. Europe Atrial Fibrillation Devices Market Size and Volume Forecast by Type
      11.7.1. Catheter Ablation
      11.7.2. Maze Surgery
   11.8. Basis Poit Share (BPS) Analysis by Type
   11.9. Y-o-Y Growth Projections by Type
   11.10. Market Attractiveness/Growth Potential Analysis
      11.10.1. By Country
      11.10.2. By Product Type
      11.10.3. By Application
      11.10.4. By Sales Channel
   11.11. Europe Atrial Fibrillation Devices Demand Share, 2019-2026

12. Asia Pacific Atrial Fibrillation Devices Market Analysis and Forecast
   12.1. Introduction
      12.1.1. Basis Point Share (BPS) Analysis by Country
      12.1.2. Y-o-Y Growth Projections by Country
      12.1.3. Asia Pacific Average Pricing Analysis
   12.2. Asia Pacific Atrial Fibrillation Devices Market Size and Volume Forecast by Country
      12.2.1. China
      12.2.2. Japan
      12.2.3. South Korea
      12.2.4. India
      12.2.5. Australia
      12.2.6. Rest of Asia Pacific (APAC)
   12.3. Absolute $ Opportunity Assessment by Country
   12.4. Asia Pacific Atrial Fibrillation Devices Market Size and Volume Forecast by Application
      12.4.1. Hospitals
      12.4.2. Clinics
      12.4.3. Ambulatory Surgical Centers
      12.4.4. Others
   12.5. Basis Point Share (BPS) Analysis by Application
   12.6. Y-o-Y Growth Projections by Application
   12.7. Asia Pacific Atrial Fibrillation Devices Market Size and Volume Forecast by Type
      12.7.1. Catheter Ablation
      12.7.2. Maze Surgery
   12.8. Basis Point Share (BPS) Analysis by Type
   12.9. Y-o-Y Growth Projections by Type
   12.10. Market Attractiveness/Growth Potential Analysis
      12.10.1. By Country
      12.10.2. By Product Type
      12.10.3. By Application
      12.10.4. By Sales Channel
   12.11. Asia Pacific Atrial Fibrillation Devices Demand Share, 2019-2026

13. Middle East & Africa Atrial Fibrillation Devices Market Analysis and Forecast
   13.1. Introduction
      13.1.1. Basis Point Share (BPS) Analysis by Country
      13.1.2. Y-o-Y Growth Projections by Country
      13.1.3. Asia Pacific Average Pricing Analysis
   13.2. Middle East & Africa Atrial Fibrillation Devices Market Size and Volume Forecast by Country
      13.2.1. Saudi Arabia
      13.2.2. South Africa
      13.2.3. UAE
      13.2.4. Rest of Middle East & Africa (MEA)
   13.3. Absolute $ Opportunity Assessment by Country
   13.4. Middle East & Africa Atrial Fibrillation Devices Market Size and Volume Forecast by Application
      13.4.1. Hospitals
      13.4.2. Clinics
      13.4.3. Ambulatory Surgical Centers
      13.4.4. Others
   13.5. Basis Point Share (BPS) Analysis by Application
   13.6. Y-o-Y Growth Projections by Application
   13.7. Middle East & Africa Atrial Fibrillation Devices Market Size and Volume Forecast by Type
      13.7.1. Catheter Ablation
      13.7.2. Maze Surgery
   13.8. Basis Point Share (BPS) Analysis by Type
   13.9. Y-o-Y Growth Projections by Type
   13.10. Market Attractiveness/Growth Potential Analysis
      13.10.1. By Country
      13.10.2. By Product Type
      13.10.3. By Application
      13.10.4. By Sales Channel
   13.11. Middle East & Africa Atrial Fibrillation Devices Demand Share, 2019-2026

14. Competition Landscape
   14.1. Global Atrial Fibrillation Devices Market: Market Share Analysis
   14.2. Atrial Fibrillation Devices Distributors and Customers
   14.3. Atrial Fibrillation Devices Market: Competitive Dashboard
   14.4. Company Profiles (Details – Overview, Financials, Developments, Strategy) 
      14.4.1. Abbott
         14.4.1.1. Overview
         14.4.1.2. Financials
         14.4.1.3. Developments
         14.4.1.4. Strategic Outlook
      14.4.2. Boston Scientific
         14.4.2.1. Overview
         14.4.2.2. Financials
         14.4.2.3. Developments
         14.4.2.4. Strategic Outlook
      14.4.3. Biosense Webster
         14.4.3.1. Overview
         14.4.3.2. Financials
         14.4.3.3. Developments
         14.4.3.4. Strategic Outlook
      14.4.4. Medtronic
         14.4.4.1. Overview
         14.4.4.2. Financials
         14.4.4.3. Developments
         14.4.4.4. Strategic Outlook
      14.4.5. Japan Lifeline
         14.4.5.1. Overview
         14.4.5.2. Financials
         14.4.5.3. Developments
         14.4.5.4. Strategic Outlook
      14.4.6. AtriCure
         14.4.6.1. Overview
         14.4.6.2. Financials
         14.4.6.3. Developments
         14.4.6.4. Strategic Outlook
      14.4.7. Biotronik
         14.4.7.1. Overview
         14.4.7.2. Financials
         14.4.7.3. Developments
         14.4.7.4. Strategic Outlook
      14.4.8. Philips
         14.4.8.1. Overview
         14.4.8.2. Financials
         14.4.8.3. Developments
         14.4.8.4. Strategic Outlook
      14.4.9. Synaptic Medical
         14.4.9.1. Overview
         14.4.9.2. Financials
         14.4.9.3. Developments
         14.4.9.4. Strategic Outlook
      14.4.10. Osypka AG
         14.4.10.1. Overview
         14.4.10.2. Financials
         14.4.10.3. Developments
         14.4.10.4. Strategic Outlook
      14.4.11. MicroPort Scientific
         14.4.11.1. Overview
         14.4.11.2. Financials
         14.4.11.3. Developments
         14.4.11.4. Strategic Outlook
      14.4.12. CardioFocus
         14.4.12.1. Overview
         14.4.12.2. Financials
         14.4.12.3. Developments
         14.4.12.4. Strategic Outlook
      14.4.13. Lepu Medical
         14.4.13.1. Overview
         14.4.13.2. Financials
         14.4.13.3. Developments
         14.4.13.4. Strategic Outlook
      14.4.14. APT Med
         14.4.14.1. Overview
         14.4.14.2. Financials
         14.4.14.3. Developments
         14.4.14.4. Strategic Outlook
      14.4.15. TZ Medical
         14.4.15.1. Overview
         14.4.15.2. Financials
         14.4.15.3. Developments
         14.4.15.4. Strategic Outlook
      14.4.16. COMPANY 16
         14.4.16.1. Overview
         14.4.16.2. Financials
         14.4.16.3. Developments
         14.4.16.4. Strategic Outlook
      14.4.17. COMPANY 17
         14.4.17.1. Overview
         14.4.17.2. Financials
         14.4.17.3. Developments
         14.4.17.4. Strategic Outlook
      14.4.18. COMPANY 18
         14.4.18.1. Overview
         14.4.18.2. Financials
         14.4.18.3. Developments
         14.4.18.4. Strategic Outlook
      14.4.19. COMPANY 19
         14.4.19.1. Overview
         14.4.19.2. Financials
         14.4.19.3. Developments
         14.4.19.4. Strategic Outlook
      14.4.20. COMPANY 20
         14.4.20.1. Overview
         14.4.20.2. Financials
         14.4.20.3. Developments
         14.4.20.4. Strategic Outlook

Our Trusted Clients

Contact Us